myocardial hypertrophy I42.1 I42.2 I11.0 E85.3
Conditions
Interventions
Group 1: Patients with cardiological symptoms, thickened interventricular septum on echocardiography and unclear underlying cause after general cardiological evaluation will undergo extended structred
Sponsors
Klinik III für Innere Medizin, Herzzentrum, Universitätsklinik Köln
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: cardiological symptoms thickening of interventrucular septum (>12mm?, >11mm?) in echo underlying disease/cause unclear after initial evaluation
Exclusion criteria
Exclusion criteria: lack of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Portion (%) of patients with definitive diagnosis of an underlying disease at the end of a structered assessment including history, ECG, laborratory tests and imaging | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Frequency distribution of causes of myocardial thickening in a cardiological realworld cohort - n (%) of underlying diseases 2. n (%) of patients with final diagnosis of transthyretin cardiomyopathy according to disease stages NAC I-II-III, compared to a historical cohort of the hospital from years 2022-2024 3. Accuracy of red flags from the literature for prediction of diagnosis of cardiac amyloidosis | — |
Countries
Germany
Contacts
Public ContactRoman Pfister
Klinik III für Innere Medizin, Herzzentrum, Universitätsklinik Köln
Outcome results
None listed